Niacinamide

Niacinamide

SCHEMBL5712641

CCCCC.NC(=O)c1cccnc1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 1/20 0.76
F3 P13726 1/20 0.76
SARM1 Q6SZW1 1/20 0.76
SIRT2 Q8IXJ6 1/20 0.76
SIRT6 Q8N6T7 1/20 0.76
SIRT1 Q96EB6 1/20 0.76
SIRT3 Q9NTG7 1/20 0.76
SIRT5 Q9NXA8 1/20 0.76
SIRT4 Q9Y6E7 1/20 0.76
L3MBTL1 Q9Y468 1/20 0.60
LMNA P02545 5/20 0.57
HDAC3 O15379 1/20 0.57
HDAC1 Q13547 1/20 0.57
HDAC2 Q92769 1/20 0.57
CYP1A2 P05177 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
CYP2C19 P33261 1/20 0.55
ALDH1A1 P00352 4/20 0.52
APP P05067 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Niacinamide SCHEMBL11742728 0.93 F7 (0.81) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL28756091 0.92 F7 (0.69) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL5712635 0.90 F7 (0.76) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL10977704 0.89 F7 (0.81) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL5712662 0.89 F7 (0.81) F7F3SARM1SIRT2SIRT6
Cetostearyl Alcohol SCHEMBL28998932 0.89 F7 (0.65) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL27626287 0.89 F7 (0.65) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL23576525 0.89 F7 (0.96) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL27671762 0.87 F7 (0.92) F7F3SARM1SIRT2SIRT6
Niacinamide SCHEMBL5712652 0.87 F7 (0.92) F7F3SARM1SIRT2SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613597-A1 6-SUBSTITUTED NICOTINAMIDE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2006-01-11 EP disclosed
WO-2004080968-A1 6-SUBSTITUTED NICOTINAMIDE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2004-09-23 WO disclosed